Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

NCT03752242 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment stopped for chemistry work on investigational product.

Conditions

Acne Vulgaris

Interventions

DRUG: BMX-010 0.3%

Sponsor

BioMimetix JV, LLC